EGFR and Prion Protein Promote Signaling via FOXO3a-KLF5 Resulting in Clinical Resistance to Platinum Agents in Colorectal Cancer

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12411
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer

Nature
Multidisciplinary
2012English

Molecular Determinants of Anti-Egfr Sensitivity and Resistance in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

mTOR Signaling Mediates Resistance to Tankyrase Inhibitors in WNT-Driven Colorectal Cancer

Oncotarget
Oncology
2017English

Protein-Intrinsic and Signaling Network-Based Sources of Resistance to EGFR- And ErbB Family-Targeted Therapies in Head and Neck Cancer

Drug Resistance Updates
Cancer ResearchOncologyInfectious DiseasesPharmacology
2011English

Colorectal Cancer Cell-Derived CCL20 Recruits Regulatory T Cells to Promote Chemoresistance via FOXO1/CEBPB/NF-κB Signaling

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling

Physiological Reviews
MedicinePhysiologyMolecular Biology
2016English

RhoA Regulates Resistance to Irinotecan by Regulating Membrane Transporter and Apoptosis Signaling in Colorectal Cancer

Oncotarget
Oncology
2016English

Cancer‐associated Fibroblasts Secrete Wnt2 to Promote Cancer Progression in Colorectal Cancer

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy